choline kinase alpha inhibitor TCD-717
Term · Oncology and biomedicine · MLC-T-ONC-012582
A small-molecule inhibitor of choline kinase alpha (CHKA), with potential antineoplastic activity. TCD-717 targets and binds to CHKA, an enzyme that plays a key role in the synthesis of phosphatidylcholine, the major phospholipid in eukaryotic cell membranes. Blockade of this enzyme induces cells to activate a different route for phospholipid production which causes a toxic effect and eventually leads to cell destruction. CHKA, overexpressed in human cancer cells while only minimally expressed in normal cells, appears to play a significant role in cellular proliferation, evasion of apoptosis, increased cell motility and metastasis.
| Identifier | MLC-T-ONC-012582 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | CHKA inhibitor TCD-717 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012582",
"term": "choline kinase alpha inhibitor TCD-717",
"field": "Oncology and biomedicine",
"definition": "A small-molecule inhibitor of choline kinase alpha (CHKA), with potential antineoplastic activity. TCD-717 targets and binds to CHKA, an enzyme that plays a key role in the synthesis of phosphatidylcholine, the major phospholipid in eukaryotic cell membranes. Blockade of this enzyme induces cells to activate a different route for phospholipid production which causes a toxic effect and eventually leads to cell destruction. CHKA, overexpressed in human cancer cells while only minimally expressed in normal cells, appears to play a significant role in cellular proliferation, evasion of apoptosis, increased cell motility and metastasis.",
"abbreviation": "CHKA inhibitor TCD-717",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/choline-kinase-alpha-inhibitor-tcd-717/"
}
Record 4,773 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.